iCamuno Biotherapeutics Ltd.
iCamuno Biotherapeutics Ltd.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Stereotactic Intracerebral Injection of Allogenic IPSC-DAPs in Patients With Parkinson's Disease | Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Not yet recruiting | Phase 1 | 2026-02-11 | NCT07212088 | |
| Stereotactic Intracerebral Injection of IPSC-DAPs in Patients with Parkinson's Disease | Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Not yet recruiting | Phase 1 | 2025-02-12 | NCT06821529 |